BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 37079222)

  • 1. Neuroprotective Role of DPP-4 Inhibitor Linagliptin Against Neurodegeneration, Neuronal Insulin Resistance and Neuroinflammation Induced by Intracerebroventricular Streptozotocin in Rat Model of Alzheimer's Disease.
    Siddiqui N; Ali J; Parvez S; Najmi AK; Akhtar M
    Neurochem Res; 2023 Sep; 48(9):2714-2730. PubMed ID: 37079222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linagliptin, a DPP-4 inhibitor, ameliorates Aβ (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer's disease.
    Siddiqui N; Ali J; Parvez S; Zameer S; Najmi AK; Akhtar M
    Neuropharmacology; 2021 Sep; 195():108662. PubMed ID: 34119519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective role of astaxanthin in hippocampal insulin resistance induced by Aβ peptides in animal model of Alzheimer's disease.
    Rahman SO; Panda BP; Parvez S; Kaundal M; Hussain S; Akhtar M; Najmi AK
    Biomed Pharmacother; 2019 Feb; 110():47-58. PubMed ID: 30463045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alogliptin reversed hippocampal insulin resistance in an amyloid-beta fibrils induced animal model of Alzheimer's disease.
    Rahman SO; Kaundal M; Salman M; Shrivastava A; Parvez S; Panda BP; Akhter M; Akhtar M; Najmi AK
    Eur J Pharmacol; 2020 Dec; 889():173522. PubMed ID: 32866503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DPP-4 Inhibitor Linagliptin Attenuates Aβ-induced Cytotoxicity through Activation of AMPK in Neuronal Cells.
    Kornelius E; Lin CL; Chang HH; Li HH; Huang WN; Yang YS; Lu YL; Peng CH; Huang CN
    CNS Neurosci Ther; 2015 Jul; 21(7):549-57. PubMed ID: 26010513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
    Kosaraju J; Holsinger RMD; Guo L; Tam KY
    Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sodium orthovanadate improves learning and memory in intracerebroventricular-streptozotocin rat model of Alzheimer's disease through modulation of brain insulin resistance induced tau pathology.
    Akhtar A; Bishnoi M; Sah SP
    Brain Res Bull; 2020 Nov; 164():83-97. PubMed ID: 32784004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Saxagliptin: a dipeptidyl peptidase-4 inhibitor ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Gali CC; Khatwal RB; Dubala A; Chinni S; Holsinger RM; Madhunapantula VS; Muthureddy Nataraj SK; Basavan D
    Neuropharmacology; 2013 Sep; 72():291-300. PubMed ID: 23603201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway.
    Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP
    Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Streptozotocin Intracerebroventricular-Induced Neurotoxicity and Brain Insulin Resistance: a Therapeutic Intervention for Treatment of Sporadic Alzheimer's Disease (sAD)-Like Pathology.
    Kamat PK; Kalani A; Rai S; Tota SK; Kumar A; Ahmad AS
    Mol Neurobiol; 2016 Sep; 53(7):4548-62. PubMed ID: 26298663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease.
    de la Monte SM; Tong M; Schiano I; Didsbury J
    J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
    Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
    Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Roflumilast Reduces Pathological Symptoms of Sporadic Alzheimer's Disease in Rats Produced by Intracerebroventricular Streptozotocin by Inhibiting NF-κB/BACE-1 Mediated Aβ Production in the Hippocampus and Activating the cAMP/BDNF Signalling Pathway.
    Hasan N; Zameer S; Najmi AK; Parvez S; Akhtar M
    Neurotox Res; 2022 Apr; 40(2):432-448. PubMed ID: 35192144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cinnamaldehyde Regulates Insulin and Caspase-3 Signaling Pathways in the Sporadic Alzheimer's Disease Model: Involvement of Hippocampal Function via IRS-1, Akt, and GSK-3β Phosphorylation.
    Bagheri-Mohammadi S; Askari S; Alani B; Moosavi M; Ghasemi R
    J Mol Neurosci; 2022 Nov; 72(11):2273-2291. PubMed ID: 36210429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 protects hippocampal neurons against advanced glycation end product-induced tau hyperphosphorylation.
    Chen S; An FM; Yin L; Liu AR; Yin DK; Yao WB; Gao XD
    Neuroscience; 2014 Jan; 256():137-46. PubMed ID: 24183963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 7,8-Dihydroxyflavone improves cognitive functions in ICV-STZ rat model of sporadic Alzheimer's disease by reversing oxidative stress, mitochondrial dysfunction, and insulin resistance.
    Akhtar A; Dhaliwal J; Sah SP
    Psychopharmacology (Berl); 2021 Jul; 238(7):1991-2009. PubMed ID: 33774703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of bergenin in Alzheimer's disease: Investigation through molecular docking, in vitro and in vivo studies.
    Barai P; Raval N; Acharya S; Borisa A; Bhatt H; Acharya N
    Behav Brain Res; 2019 Jan; 356():18-40. PubMed ID: 30118774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dipeptidyl peptidase-4 inhibition by Pterocarpus marsupium and Eugenia jambolana ameliorates streptozotocin induced Alzheimer's disease.
    Kosaraju J; Madhunapantula SV; Chinni S; Khatwal RB; Dubala A; Muthureddy Nataraj SK; Basavan D
    Behav Brain Res; 2014 Jul; 267():55-65. PubMed ID: 24667360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. α7nAChR activation protects against oxidative stress, neuroinflammation and central insulin resistance in ICV-STZ induced sporadic Alzheimer's disease.
    Yamini P; Ray RS; Yadav S; Dhaliwal J; Yadav M; Kondepudi KK; Chopra K
    Pharmacol Biochem Behav; 2022 Jun; 217():173402. PubMed ID: 35533773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4.
    Chen S; Liu AR; An FM; Yao WB; Gao XD
    Age (Dordr); 2012 Oct; 34(5):1211-24. PubMed ID: 21901364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.